AAAAAA

   
Results: 1-13 |
Results: 13

Authors: Laucirica, R Schwartz, MR
Citation: R. Laucirica et Mr. Schwartz, Clinical utility of flow cytometry in body fluid cytology: To flow or not to flow? That is the question, DIAGN CYTOP, 24(5), 2001, pp. 305-306

Authors: Truong, LD Caraway, N Ngo, T Laucirica, R Katz, R Ramzy, I
Citation: Ld. Truong et al., Renal lymphoma - The diagnostic and therapeutic roles of fine-needle aspiration, AM J CLIN P, 115(1), 2001, pp. 18-31

Authors: Mann, S Laucirica, R Carlson, N Younes, PS Ali, N Younes, A Li, Y Younes, M
Citation: S. Mann et al., Estrogen receptor beta expression in invasive breast cancer, HUMAN PATH, 32(1), 2001, pp. 113-118

Authors: Zahnow, CA Cardiff, RD Laucirica, R Medina, D Rosen, JM
Citation: Ca. Zahnow et al., A role for CCAAT/enhancer binding protein beta-liver-enriched inhibitory protein in mammary epithelial cell proliferation, CANCER RES, 61(1), 2001, pp. 261-269

Authors: Ostrowski, ML Pindur, J Laucirica, R Chakraborty, S Ramzy, I
Citation: Ml. Ostrowski et al., Proliferative activity in invasive breast carcinoma - A comprehensive comparison of MIB-1 immunocytochemical staining in aspiration biopsies to imageanalytic, flow cytometric and histologic parameters, ACT CYTOL, 45(6), 2001, pp. 965-972

Authors: Li, ML Lewis, B Capuco, AV Laucirica, R Furth, PA
Citation: Ml. Li et al., WAP-TAg transgenic mice and the study of dysregulated cell survival, proliferation, and mutation during breast carcinogenesis, ONCOGENE, 19(8), 2000, pp. 1010-1019

Authors: Jerry, DJ Kittrell, FS Kuperwasser, C Laucirica, R Dickinson, ES Bonilla, PJ Butel, JS Medina, D
Citation: Dj. Jerry et al., A mammary-specific model demonstrates the role of the p53 tumor suppressorgene in tumor development, ONCOGENE, 19(8), 2000, pp. 1052-1058

Authors: Hadsell, DL Murphy, KL Bonnette, SG Reece, N Laucirica, R Rosen, JM
Citation: Dl. Hadsell et al., Cooperative interaction between mutant p53 and des(1-3)IGF-I accelerates mammary tumorigenesis, ONCOGENE, 19(7), 2000, pp. 889-898

Authors: Shariat, SF Weizer, AZ Green, A Laucirica, R Frolov, A Wheeler, TM Lerner, SP
Citation: Sf. Shariat et al., Prognostic value of p55 nuclear accumulation and histopathologic features in T1 transitional cell carcinoma of the urinary bladder, UROLOGY, 56(5), 2000, pp. 735-740

Authors: Kuperwasser, C Hurlbut, GD Kittrell, FS Dickinson, ES Laucirica, R Medina, D Naber, SP Jerry, DJ
Citation: C. Kuperwasser et al., Development of spontaneous mammary tumors in BALB/c p53 heterozygous mice - A model for Li-Fraumeni syndrome, AM J PATH, 157(6), 2000, pp. 2151-2159

Authors: Furth, PA Bar-Peled, U Li, ML Lewis, A Laucirica, R Jager, R Weiher, H Russell, RG
Citation: Pa. Furth et al., Loss of anti-mitotic effects of Bcl-2 with retention of anti-apoptotic activity during tumor progression in a mouse model, ONCOGENE, 18(47), 1999, pp. 6589-6596

Authors: Tyner, SD Choi, J Laucirica, R Ford, RJ Donehower, LA
Citation: Sd. Tyner et al., Increased tumor cell proliferation in murine tumors with decreasing dosageof wild-type p53, MOL CARCINO, 24(3), 1999, pp. 197-208

Authors: Singh, G Lakkis, CL Laucirica, R Epner, DE
Citation: G. Singh et al., Regulation of prostate cancer cell division by glucose, J CELL PHYS, 180(3), 1999, pp. 431-438
Risultati: 1-13 |